Regeneron Pharmaceuticals
Price & Volume
Stats
See more52W Range | $474.60-$820.12 |
Market Cap | $81.6B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $14.3B |
Revenue Growth (YoY) | 2.5% |
Gross Profit (12 Mos) | $6.3B |
Diluted EPS | $41.47 |
News
See moreYahoo Finance • 2 days ago
Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
Yahoo Finance • 2 days ago
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
Yahoo Finance • 2 days ago
Communiqué de presse : Dupixent de Sanofi et Regeneron est approuvé aux États-Unis comme le premier et le seul médicament pour la rhinosinusite fongique allergique
Yahoo Finance • 4 days ago
1 No-Brainer Biotech Stock To Buy Today and Never Sell
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15,410 |
